Showing results (301-310 of 343) with videos related to
Sort By:
Pageof 35
Science Signaling|October 18, 2022
Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signalingBarath Udayasuryan, Raffae N Ahmad, Tam T D Nguyen, et al.BJOG : an International Journal of Obstetrics and Gynaecology|December 6, 2023
Blood pressure measurement and adverse pregnancy outcomes: A cohort study testing blood pressure variability and alternatives to 140/90 mmHgMilly G Wilson, Jeffrey N Bone, Laura J Slade, et al.Plos One|September 15, 2021
Development of non-transgenic glyphosate tolerant wheat by TILLINGCharles P Moehs, William J Austill, Daniel Facciotti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancerE June Davies, Fiona H Blackhall, Jonathan H Shanks, et al.Nature Communications|February 21, 2024
Chiral and flat-band magnetic quasiparticles in ferromagnetic and metallic kagome layersS X M Riberolles, Tyler J Slade, Tianxiong Han, et al.Clinical Transplantation|September 2, 2009
FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter studyH Tedesco-Silva, M I Lorber, C E Foster, et al.Communications Biology|May 8, 2024
Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent mannerBarath Udayasuryan, Zirui Zhou, Raffae N Ahmad, et al.The Journal of Endocrinology|April 17, 2003
Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cellsC Palmieri, D Roberts-Clark, A Assadi-Sabet, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
p53 and related proteins in epithelial ovarian cancerP S Sengupta, A T McGown, V Bajaj, et al.International Journal of Cancer|November 4, 2004
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 yearsMartin J Slade, Anjana Singh, Brendan M Smith, et al.Pageof 35